Opti Medical Systems Receives EUA for SARS-CoV-2 RNA PCR Test Kit
To diagnose covid-19, the kit is authorized to detect SARS-CoV-2 RNA from bronchoalveolar lavage, nasopharyngeal swabs, oropharyngeal swabs, and sputum.
Read MorePosted by Laurie Bonner | May 14, 2020 | Covid 19, Uncategorized |
To diagnose covid-19, the kit is authorized to detect SARS-CoV-2 RNA from bronchoalveolar lavage, nasopharyngeal swabs, oropharyngeal swabs, and sputum.
Read MorePosted by Laurie Bonner | May 13, 2020 | Covid 19, Uncategorized |
Using the company’s namesake method, the covid-19 kit works by programming a CRISPR molecule to detect the genetic signature of the SARS-CoV-2 virus.
Read MorePosted by Laurie Bonner | May 13, 2020 | Covid 19, Uncategorized |
The agency’s changes include making it easier for Medicare and Medicaid beneficiaries to get tested for covid-19.
Read MorePosted by Laurie Bonner | May 12, 2020 | Covid 19, Uncategorized |
The mobile app enables the health system to provide patients with virtual triage, real-time notifications, and navigation to testing and treatment sites.
Read MorePosted by Laurie Bonner | May 12, 2020 | Covid 19, Uncategorized |
The new immunological assay for covid-19 joins the lab’s molecular diagnostic, released in March to detect SARS-CoV-2 viral RNA in respiratory swab specimens.
Read More